<h1>Global research organization invests in Boston healthcare AI company to automate patient identification and improve clinical trial recruitment efficiency</h1> A global contract research organization announced an investment in a Boston-based healthcare AI company to enhance clinical trials services. The partnership will leverage an AI-powered platform to automate patient identification, improve recruitment efficiency, and expand reach across Europe. The collaboration aims to transform the organization into an AI-driven oncology drug development company, addressing regulatory demands for diversity in clinical trials. The platform integrates large language models and generative AI to improve operational efficiencies and real-world evidence, supporting better patient matching and trial design while reducing costs and timelines.